Methylthioadenosine Phosphorylase as Target for Chemoselective Treatment of T-Cell Acute Lymphoblastic Leukemic Cells
- 31 January 2002
- journal article
- Published by Elsevier in Blood Cells, Molecules, and Diseases
- Vol. 28 (1) , 47-56
- https://doi.org/10.1006/bcmd.2002.0483
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The INK4a/ARF network in tumour suppressionNature Reviews Molecular Cell Biology, 2001
- Acute myeloid leukemia in adults: where do we go from here?Cancer Chemotherapy and Pharmacology, 2001
- Comparative genomic hybridization in childhood acute lymphoblastic leukemiaCancer Genetics and Cytogenetics, 2001
- Importance of using comparative genomic hybridization to improve detection of chromosomal changes in childhood acute lymphoblastic leukemiaCancer Genetics and Cytogenetics, 2000
- Cytotoxicity of Trimetrexate against Antifolate‐resistant Human T‐Cell Leukemia Cell Lines Developed in Oxidized or Reduced FolateJapanese Journal of Cancer Research, 1997
- Anti-Fas/Apo-1 Monoclonal Antibody CH-11 Depletes Glutathione and Kills Multidrug-Resistant Human Leukemic CellsBlood Cells, Molecules, and Diseases, 1996
- Frequency of homozygous deletion at p16/CDKN2 in primary human tumoursNature Genetics, 1995
- Cell cycle control and cancer chemotherapyJournal of Cellular Biochemistry, 1994
- Modulation of P-Glycoprotein-Mediated Multidrug Resistance by Monoclonal Antibodies, Immunotoxins or Antisense Oligodeoxynucleotides in Kidney Carcinoma and Normal Kidney CellsOncology, 1993
- Methylthioadenosine nucleoside phosphorylase deficiency in methylthio-dependent cancer cellsBiochemical and Biophysical Research Communications, 1978